416 related articles for article (PubMed ID: 31698891)
1. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
2. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
3. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
[TBL] [Abstract][Full Text] [Related]
4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
7. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
8. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
9. Primary human papillomavirus testing in organized cervical screening.
Dillner J
Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa.
Tsu VD; Njama-Meya D; Lim J; Murray M; de Sanjose S
Prev Med; 2018 Sep; 114():205-208. PubMed ID: 30031013
[TBL] [Abstract][Full Text] [Related]
11. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
Tanzi E; Bianchi S; Fappani C; Gori M; Colzani D; Passera I; Tincati C; Canuti M; Raviglione M; Amendola A
J Med Virol; 2023 May; 95(5):e28802. PubMed ID: 37219045
[TBL] [Abstract][Full Text] [Related]
13. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
[TBL] [Abstract][Full Text] [Related]
15. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
[TBL] [Abstract][Full Text] [Related]
16. Screening for cervical cancer and human papilloma virus: Indian context.
Deodhar KK
Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
[TBL] [Abstract][Full Text] [Related]
17. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
[TBL] [Abstract][Full Text] [Related]
18. Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies.
Ribeiro A; Corrêa F; Migowski A; Leal A; Martins S; Raiol T; Marques CP; Torres KL; Novetsky AP; Marcus JZ; Wentzensen N; Schiffman M; Rodriguez AC; Gage JC
Cancer Prev Res (Phila); 2021 Oct; 14(10):919-926. PubMed ID: 34607876
[TBL] [Abstract][Full Text] [Related]
19. The time is now to implement HPV testing for primary screening in low resource settings.
Kuhn L; Denny L
Prev Med; 2017 May; 98():42-44. PubMed ID: 28279263
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in low- and middle-income countries.
Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
